* Privia Health Group Inc PRVA.OQ PRVA.O is expected
to show a
rise in quarterly revenue when it reports results on November
10.
* The Arlington Virginia-based company is expected to
report a
111.0% increase in revenue to $530.663 million from $251.52
million a year ago, according to the mean estimate from 10
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Privia Health Group
Inc
is for breakeven results per share.
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 13 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Privia
Health
Group Inc is $45.5, above its last closing price of $28.41.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.02 -0.03 0.14 Beat 636.2
Mar. 31 2022 -0.05 -0.04 -0.16 Missed -340.4
Dec. 31 2021 -0.18 -0.13 -0.11 Beat 17.7
Sep. 30 2021 -0.09 -0.11 -0.09 Beat 16.9
Jun. -1.76 -1.69 -1.68 Beat 0.6
30 2021
Mar. 31 2021 0.04 0.04 0.06 Beat 36.9
This summary was machine generated November 8 at 17:45 GMT. All
figures in US dollars unless otherwise stated